Key takeaway
In 14 overweight women with polycystic ovary syndrome (PCOS), 12 weeks on a ketogenic Mediterranean diet with phytoextracts was followed by a 9.43 kg drop in body weight and improvements in insulin, cholesterol and sex hormones. There was no control group and only 14 women, so the diet's own effect is unproven.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
PCOS is the most common endocrine disorder in women of reproductive age, and insulin resistance plays a key role. The authors set out to see how a ketogenic diet changes body composition, metabolic markers, hormones and hair-growth score in women of childbearing age with PCOS.
Who and how
Single-arm, before-and-after study of 14 overweight women with a PCOS diagnosis, who followed a ketogenic Mediterranean diet with phytoextracts (KEMEPHY) for 12 weeks. The authors compared body weight, BMI, fat mass, lean mass, visceral adipose tissue, glucose, insulin, HOMA-IR, lipids, sex hormones and the Ferriman Gallwey hair score before and after. The trial was registered retrospectively (NCT04163120). The abstract does not give P values or the statistical tests.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Body weight fell by 9.43 kg, BMI by 3.35 and fat body mass by 8.29 kg, with a significant fall in visceral fat and a small but significant decrease in lean mass.
- 2Glucose and insulin fell significantly and HOMA-IR, a measure of insulin resistance, improved significantly.
- 3Triglycerides, total cholesterol and LDL fell and HDL rose, all significantly.
- 4The LH/FSH ratio, LH, total and free testosterone and DHEAS fell significantly, while estradiol, progesterone and SHBG rose. The Ferriman Gallwey score fell slightly but not significantly.
Limits & uncertainty
- 1No control group and only 14 women, so weight loss itself, regression to the mean or other changes cannot be separated from the ketogenic diet.
- 2The diet combined ketosis, a Mediterranean pattern and phytoextracts, so the abstract cannot say which part mattered.
- 3Trial registration was retrospective, the follow-up ended at 12 weeks, and the abstract gives no data on safety, adherence or what happens after stopping. This reading is based on the abstract only.
What to take from it
Large weight loss in women with PCOS tends to improve metabolic and hormone markers, and this small study saw that with a ketogenic Mediterranean diet. It does not show that this diet is better than other diets or safe for long periods. Anyone with PCOS should plan diet changes with their clinician.
Reading your own data
Body weight and waist circumference are easy to track on a consistent scale at the same time of day, and a food log shows adherence. Glucose or lipid changes need lab tests or a CGM under clinical guidance; look at trends over weeks, not single readings.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during reproductive age. It is characterised clinically by oligo-ovulation or anovulation, hyper-androgenism, and the presence of polycystic ovaries. It is associated with an increased prevalence of metabolic syndrome, cardiovascular disease and type 2 diabetes. The onset of PCOS has been associated to several hereditary and environmental factors, but insulin resistance plays a key pathogenetic role. We sought to investigate the effects of a ketogenic diet (KD) on women of childbearing age with a diagnosis of PCOS.
Methods
Fourteen overweight women with diagnosis of PCOS underwent to a ketogenic Mediterranean diet with phyoextracts (KEMEPHY) for 12 week. Changes in body weight, body mass index (BMI), fat body mass (FBM), lean body mass (LBM), visceral adipose tissue (VAT), insulin, glucose, HOMA-IR, total cholesterol, low density lipoprotein (LDL), high density lipoprotein (HDL), triglycerides (TGs), total and free testosterone, luteinizing hormone (LH), follicle stimulating hormone (FSH); dehydroepiandrosterone sulfate (DHEAs), estradiol, progesterone, sex hormone binding globulin (SHBG) and Ferriman Gallwey score were evaluated.
Results
After 12 weeks, anthropometric and body composition measurements revealed a significant reduction of body weight (- 9.43 kg), BMI (- 3.35), FBM (8.29 kg) and VAT. There was a significant, slightly decrease of LBM. A significant decrease in glucose and insulin blood levels were observed, together with a significant improvement of HOMA-IR. A significant decrease of triglycerides, total cholesterol and LDL were observed along with a rise in HDL levels. The LH/FSH ratio, LH total and free testosterone, and DHEAS blood levels were also significantly reduced. Estradiol, progesterone and SHBG increased. The Ferriman Gallwey Score was slightly, although not significantly, reduced.
Conclusions
Our results suggest that a KD may be considered as a valuable non pharmacological treatment for PCOS. Longer treatment periods should be tested to verify the effect of a KD on the dermatological aspects of PCOS. Trial registration Clinicaltrial.gov, NCT04163120, registrered 10 November 2019, retrospectively registered, https://clinicaltrials.gov.
Sources & attribution
Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M.
Journal of translational medicine · 2020-02-27
DOI: 10.1186/s12967-020-02277-0 ↗PubMed · 32103756 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

